We met some amazing people and organizations today who are championing research and support for breast cancer patients. The full continuum of cancer care was present in strength today for #PinkOutTheStatehouse. So happy @mindidill.bsky.social could join me for this event.

Strange, but sadly not surprising. Here’s what I’m seeing now.

Congratulations, Dr. Noah Hahn of Johns Hopkins Kimmel Cancer Center and all co-authors on presentation of the ADAPT-BLADDER (HCRN-GU16-243) Cohort 4 results at #GU25.

Congratulations, Dr. Rana McKay and Dr. Justine Panian of the UCSD Moores Cancer Center, and all study collaborators, on your Trials in Progress poster highlighting the @hoosiercancer.bsky.social CANOPY study at #GI25. #OncSky

Well attended #GI25 poster walk led by Vaibhav Sahai, MD, MS, of the University of Michigan Rogel Cancer. Dr Sahai is co-chair of the @bigtencrc.bsky.social GI Clinical Trial Working Group.

Today I reflect on my father, who would have turned 89 yesterday. He is my exemplar of a life well lived. He was the first of my immediate family to pass from #cancer (in 2002 at 66), followed by my sister (2018 at 58) and mom (2021 at 84). Their memory motivates me daily. #HolidayReflection #OncSky

Congrats to all #BigTen cancer researchers who presented at #SABCS24. Our team managed to visit some of your posters, but there were so many others at the meeting. Wish we could have visited all! @rutgerscancer.bsky.social

We are grateful to all who joined the Hoosier Cancer Research Network #breastcancer research meeting at #SABCS24. Great discussion on currently enrolling #clinicaltrials and potential new multi-center IITs.

Annual gathering of the Big Ten CRC #breastcancer research team at #SABCS24. Great turnout and discussion! @kariwisinskimd.bsky.social

Congratulations to Rutgers University and George Mason University collaborators on your #SABCS24 poster, validation of HER2 activation response predictive signature (HARPS) as predictive biomarker for HER2+ therapy response in neoadj setting.

Excellent overview of ePRO use in #mBC, and what’s next, presented by Gabrielle Rocque, MD, of University of Alabama at Birmingham. #SABCS24 @sabcs.bsky.social

Thank you to our Hoosier Cancer Research Network #myeloid working group members for a fantastic lunch discussion during #ASH24.

Fantastic lunch meeting with Hoosier Cancer Research Network #lymphoma researchers during #ASH24. Thank you to all who attended and contributed to such a productive discussion.

Thank you to our members who joined our Big Ten CRC #myeloid and #bmt lunch at #ASH24. What a great meeting!

Great turnout for our Big Ten Cancer Research Consortium #MultipleMyeloma lunch during #ASH24. Thanks to all who joined us!

Thank you to this great group of #lymphoma researchers who gathered for lively discussion during our lunch meeting at #ASH24.

The HCRN SOLARA study evaluates the safety and effectiveness of focused radiation therapy (radiosurgery) together with olaparib, followed by immunotherapy, for patients with brain metastases from triple negative or BRCA-mutated breast cancers.

Learn more: hoosiercancer.org/clinical-tri...